A detailed history of Fjarde Ap Fonden transactions in Incyte Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 98,864 shares of INCY stock, worth $7.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
98,864
Previous 115,364 14.3%
Holding current value
$7.5 Million
Previous $6.57 Million 0.56%
% of portfolio
0.07%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$57.33 - $68.61 $945,945 - $1.13 Million
-16,500 Reduced 14.3%
98,864 $6.54 Million
Q1 2024

Apr 25, 2024

BUY
$56.55 - $66.59 $1.29 Million - $1.52 Million
22,800 Added 24.63%
115,364 $6.57 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $751,104 - $924,336
-14,400 Reduced 13.46%
92,564 $5.81 Million
Q3 2023

Oct 23, 2023

BUY
$57.77 - $65.93 $340,843 - $388,987
5,900 Added 5.84%
106,964 $6.18 Million
Q2 2023

Aug 02, 2023

BUY
$60.95 - $75.51 $1.24 Million - $1.54 Million
20,400 Added 25.29%
101,064 $6.29 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $832,225 - $1.02 Million
11,850 Added 17.22%
80,664 $5.83 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $866,957 - $1.09 Million
-12,905 Reduced 15.79%
68,814 $5.53 Million
Q2 2022

Aug 11, 2022

BUY
$66.18 - $83.18 $2.63 Million - $3.3 Million
39,700 Added 94.48%
81,719 $6.21 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $970,493 - $1.17 Million
-14,700 Reduced 25.92%
42,019 $3.34 Million
Q4 2021

Feb 15, 2022

SELL
$63.34 - $74.11 $83,988 - $98,269
-1,326 Reduced 2.28%
56,719 $4.16 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $185,409 - $226,854
2,700 Added 4.88%
58,045 $3.99 Million
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $391,363 - $428,897
-4,900 Reduced 8.13%
55,345 $4.66 Million
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $744,996 - $984,900
9,800 Added 19.43%
60,245 $4.9 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $379,478 - $459,190
-4,700 Reduced 8.52%
50,445 $4.39 Million
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $399,828 - $515,543
4,700 Added 9.32%
55,145 $4.95 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $57,712 - $84,747
778 Added 1.57%
50,445 $5.25 Million
Q1 2020

May 11, 2020

BUY
$63.18 - $85.97 $37,908 - $51,582
600 Added 1.22%
49,667 $3.64 Million
Q4 2019

Feb 10, 2020

BUY
$73.04 - $95.72 $387,112 - $507,316
5,300 Added 12.11%
49,067 $4.29 Million
Q3 2019

Oct 31, 2019

BUY
$72.82 - $86.52 $131,076 - $155,736
1,800 Added 4.29%
43,767 $3.25 Million
Q2 2019

Jul 17, 2019

SELL
$73.52 - $88.7 $551,400 - $665,250
-7,500 Reduced 15.16%
41,967 $3.57 Million
Q1 2019

Apr 29, 2019

BUY
$63.56 - $88.17 $589,709 - $818,041
9,278 Added 23.09%
49,467 $4.26 Million
Q4 2018

Jan 31, 2019

SELL
$58.5 - $69.94 $462,150 - $552,526
-7,900 Reduced 16.43%
40,189 $2.56 Million
Q3 2018

Nov 09, 2018

SELL
$61.75 - $74.23 $87,499 - $105,183
-1,417 Reduced 2.86%
48,089 $3.32 Million
Q2 2018

Jul 12, 2018

BUY
$60.85 - $83.98 $19,715 - $27,209
324 Added 0.66%
49,506 $3.32 Million
Q1 2018

May 07, 2018

BUY
$83.06 - $100.98 $156,318 - $190,044
1,882 Added 3.98%
49,182 $4.1 Million
Q4 2017

Feb 12, 2018

BUY
$93.56 - $116.6 $588,211 - $733,064
6,287 Added 15.33%
47,300 $4.48 Million
Q3 2017

Nov 07, 2017

BUY
$109.15 - $138.27 $153,792 - $194,822
1,409 Added 3.56%
41,013 $4.79 Million
Q2 2017

Aug 08, 2017

BUY
N/A
39,604
39,604 $4.99 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.